Logistics for getting cell and gene therapies to patients quickly and efficiently is something that should be considered earlier, rather than later, in the development process, according to industry experts who met in October of 2018 at the Alliance for Regenerative Medicine’s (ARM) Cell and Gene Meeting on the Mesa. Experts gathered in San Diego to discuss the importance of considering logistics early on in the development process, as cell and gene therapy gain in popularity and prominence. Explore the findings of this meeting in this eye-opening In Vivo article.